Physician profile
Haley A Ketcham
NPI 1174280903
$828.92
in general payments reported to CMS, 2019-2025
12 companies · $417 in 2025
The $417 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $76.67 · 2023: $116 · 2024: $219 · 2025: $417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $752.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $150.78 | 2024 | Impella |
| Medtronic, INC. | $125.82 | 2025 | Linq II, Tyrx, Azure Xt Dr Mri Surescan |
| Alkermes, INC. | $123.81 | 2025 | Lybalvi |
| Melinta Therapeutics, LLC | $121.83 | 2025 | Rezzayo |
| Kestra Medical Technology Services, INC. | $78.46 | 2023-2024 | Assure Wcd |
| Currax Pharmaceuticals LLC | $60.23 | 2022 | |
| Janssen Pharmaceuticals, INC | $37.30 | 2022-2023 | Xarelto |
| Mallinckrodt Hospital Products INC. | $35.36 | 2024 | Terlivaz |
| Novo Nordisk INC | $29.47 | 2025 | Ozempic |
| Chiesi USA, INC. | $28.67 | 2023-2025 | Cleviprex, Kengreal |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.76 | 2023 | Lifevest |
| Pfizer INC. | $15.43 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Ketcham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.